Lobo Cube DNA testing device for safer cannabis use gaining major media attention
An Oct. 26 article on the Washington Post web site discusses job openings in Canada’s legalized cannabis sector, highlighting an Ontario government policy advisor who left his job to join Lobo Genetics as its director of policy and communications.
The closely-held company has developed a small, portable medical device, known as the Lobo Cube, which measures a person’s genetic markers to predict how they will react to cannabis.
The Post article quotes analysts as saying that the growing number of jobs in the cannabis space, a chance to join firms with sky-high valuations and an opportunity to shape a burgeoning industry where Canada has leapfrogged the U.S. and could become a world leader are fuelling this migration.
The article can be viewed here.